Last reviewed · How we verify
Intra-arterial injection of melphalan
At a glance
| Generic name | Intra-arterial injection of melphalan |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome (PHASE2, PHASE3)
- Conservative Treatments of Retinoblastoma (PHASE2)
- Melphalan Chemoreduction for Ocular Melanoma (PHASE1, PHASE2)
- Intra-arterial Chemotherapy for Retinoblastoma (PHASE1)
- Intra-arterial Chemotherapy for Spinal Metastases (PHASE1)
- Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG). (PHASE1)
- Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma (PHASE2)
- A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: